Five new startups get the first kick

29.03.2018

Congratulations to EraCal, Fixtech, Lipidon, Nagi Bioscience and Swiss Blockchain Technology on passing stage 1 of Venture Kick and on each bringing home CHF 10,000. The startups develop innovative solutions in Medtech, Biotech, Fintech and maritime technology services.

Lipidon_news1.jpg
Lipidon
20180320_EraCal_VK1_2_news.jpg
EraCal
Fixtech_news.jpg
FIXtech
NagiBioscience_news.jpg
Nagi Bioscence
SwissBlockchain_news.jpg
Swiss Blockchain Technology
EraCal (UZH) – Medtech
EraCal aims to develop first-in-class drugs to treat the metabolic syndrome based on novel mechanism into pharmaceutical products for the world market. The approach: modulate the brain with drugs to suppress appetite allowing patients to ultimately loose body weight. At the core of the innovative technology are fifty identified appetite-suppressors, selective to food intake that do not induce neuronal side-effects and significantly outperform current anti-obesity agents in potency and in selectivity.

FIXtech (IMD Lausanne) – Hightech / Maritime technology
FIXtech is bringing connectivity and automation to the bulk commodity shipping industry. The platform (PaaS) transforms long, linear communication chains spread across the globe into collaborative (cloud-based) workstations. Users can automate communications and data transfers through the platform's API integrations, while working with their counterparties to execute voyage operations. The result is vastly improved supply chain visibility, quicker response times and reduced manual data entry.

Lipidon (UZH) – Medtech/Biotech
Lipidon aims to provide bioanalytical services focusing on actionable biomarker discovery in the fields of precision medicine, pharma, biotech, cosmetics and food. Lipidon’s technology allows for individual profiling of the metabolic state in a living organism. It can identifymetabolic fingerprints in humans, animals and plants as well as measure metabolic profiles in food, cosmetics and other consumer products.

Nagi Bioscience (EPFL) – Medtech / Biotech
Nagi Bioscience wishes to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology. It combines the use of microscopic worms as in vivo models for drug/chemical screening with the first technological platform for their fully automated in vitro culture, treatment and multi-parametric analysis. “In vivo testing at the in vitro scale” is key to boost innovation and efficiency in pharmaceutical, cosmetic, chemical industries, while contributing to the “replacement, reduction and refinement” of animal testing.

Swiss Blockchain Technology – Safekee.io project
Swiss Blockchain Technology ambitions to shape the future of crypto assets protection through Safekee, an innovative decentralized solution designed to drastically enhance the security of crypto assets and the safety of crypto-space users. 
With Safekee, Swiss Blockchain Technology introduces the world’s first-ever secure, remote and decentralized Cold–Storage keys management service, empowering individuals and organizations in protecting their crypto assets form cyber and physical attacks.
Swiss Blockchain Technology is a Lugano-based startup specialized in developing and delivering innovative hardware-based security technology solutions, with a vision to build a secure foundation for tomorrow’s Crypto Finance and tomorrow’s Blockchain-based applications.


 

Additional Links